Table 4.
HRs and 95% CI of DR incidence according to follow-up TBiL changes (μmol/L).
Variable type | HR∗ (95% CI) | P | |
---|---|---|---|
Total population (n = 5323) | Continuous variable | 0.967 (0.944–0.991) | 0.006 |
Categorical variable | 0.011 | ||
≤−2 | 1.411 (1.081–1.842) | ||
−2 to 2 | 1.00 (Ref) | ||
≥2 | 0.858 (0.770–0.947) | ||
| |||
Among those with baseline TBiL level ≤ 12.5 μmol/L (n = 2669) | Continuous variable | 0.964 (0.931–0.986) | 0.037 |
Categorical variable | 0.003 | ||
≤−2 | 1.756 (1.217–2.534) | ||
−2 to 2 | 1.00 (Ref) | ||
≥2 | 0.853 (0.761–0.934) | ||
| |||
Among those with baseline TBiL level > 12.5 μmol/L (n = 2654) | Continuous variable | 0.969 (0.936–1.003) | 0.072 |
Categorical variable | 0.794 | ||
≤−2 | 1.059 (0.689–1.626) | ||
−2 to 2 | 1.00 (Ref) | ||
≥2 | 0.864 (0.451–1.654) |
∗Adjusted for age, marital status, current smoking, current alcohol drinking, BMI, baseline Hb, ALT, baseline prevalence of hypertension and dyslipidemia, control of diabetes, duration of diabetes, and baseline TBiL levels (as continuous variable) in the model.